Latest News
B Riley has made key changes to its equity research division, aimed at strengthening the firm’s position as a small- and mid-cap broker-dealer.Mayank Mamtani was promoted to Senior Analyst and Group Head of Healthcare Research, Justin Zelin joins as Biotech Research Analyst, and Chris Souther joins as a Research Analyst focused on Clean Technology and Sustainable Energy.
“We continue to invest in our award-winning research platform with an aim to be Wall Street’s leading source of differentiated small- and mid-cap coverage. Mayank’s Healthcare Group Head appointment comes amidst unprecedented industry disruption caused by the Covid-19 pandemic and follows our
Growth Capital Partners (GCP), a UK SME private equity firm that specialises in partnering with owner-managers, has realised its investment in The DMW Group (DMW), a leading independent technology consultancy. DMW is being acquired by Credera, a subsidiary of Omnicom Group. GCP invested in DMW in October 2017 alongside the CEO, Chris Dean and the founding management team. Over the period of GCP’s investment, DMW has doubled revenue, profit and headcount to become a leading UK specialist in the design, delivery, and implementation of data-rich digital transformation programmes.
Founded over 30 years ago and headquartered in London, DMW employs technology
Funds advised by SK Capital Partners (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, is to acquire the specialty polymers business from Baker Hughes. The specialty polymers business, with manufacturing operations in Barnsdall, Oklahoma, produces specialty low molecular weight olefin polymers, including a range of differentiated functional polymers and premium, high melting point polyethylene waxes. Over its 85-year history, the business has been dedicated to innovation and has developed a strong reputation as a premium specialty supplier and solutions provider to its diverse customer base.
Mario Toukan, a Managing Director of SK
Pet owners’ love for their animals, along with the impact of Covid-19, are among the reasons private equity decision-makers feel bullish about the future of the animal care sector, according to a new survey of 100 industry leaders conducted by Katten.
Thompson Street Capital Partners (TSCP), a private equity firm based in St Louis, has completed the sale of Analytical Lab Group (ALG), a microbiology and viral lab, to Element Materials Technology (Element), one of the world’s largest providers of materials and product qualification testing, inspection and certification services to the global aerospace, transportation & industrials, connected technologies, energy, and fire & building products sectors.ALG’s team of 130 scientists and experts operates a number of FDA and EPA compliance focused laboratories in San Francisco, Minneapolis and Boston and has built a strong reputation in the infection prevention market, offering comprehensive testing
Eurazeo has completed a EUR80 million investment from its China Acceleration Fund in DORC (Dutch Ophthalmic Research Center), a specialist in the area of vitreoretinal surgery.
AnaCap Financial Partners (AnaCap), a specialist European financial services private equity firm, has promoted Edward Green, Nassim Cherchali and Tassilo Arnhold to Partner, further strengthening its senior team. As part of this promotion, the individuals will also be appointed to AnaCap’s investment committees as voting members for private equity and credit respectively.
Green joined AnaCap in 2007 as part of our Business Services team within private equity, leading operational engagement across various portfolio companies. His involvement helped Cabot Credit Management becoming a leading UK consumer debt purchasing company and First Names Group developing into a top, global corporate trust and services provider.
EMQ, an Asian financial settlement network, has issued USD20 million of Series B Preferred Shares, led by WI Harper Group, with participation from new and existing investors including Abu Dhabi Capital, AppWorks, DG Ventures, Hard Yaka, Intudo Ventures, January Capital, Quest Venture Partners, SparkLabs Taipei, Vectr Fintech Partners, and VS Partners. EMQ will use the investment to further accelerate its international growth, product development and licensing activities across Asia, Europe and the Americas.
“At EMQ, we are building a global settlement network that enables everyone to send money anywhere in the world and to any end point with a simple one-stop
Investors have rewarded the commercial success of Spotta’s smart pest systems with a USD1.18 million seed funding round. This investment reflects Spotta’s huge potential in global markets in farming, forestry, hospitality, and other sectors to solve the GBP320 billion (USD400 billion) problem of insect pests while dramatically reducing pesticide use.
Representatives of Cambridge Angels and REMUS, a US-based VC firm, will join Spotta’s board as part of the GBP934,000 (USD1,184,287) investment deal. Other major investors include Martlet Capital, Wren Capital, and the Angel CoFund.
Based in Cambridge, Spotta commercialised its first product in 2019 and has been recognised by
Advent France Biotechnology and Invivo Ventures have invested EUR4.25 million into Valencia-based Arthex Biotech, a pre-clinical stage life sciences company focused on the development of next generation antisense RNA therapies.
The latest round follows on from an initial seed round of EUR2.7 million by Invivo and CDTI-Innvierte in December 2019, and in June 2020 respectively. The total amount raised by Arthex since inception now stands at EUR6.95 million. The fresh capital will enable Arthex to complete its first-in-human trial by 2022.
“Arthex Biotech represents a unique combination of world-class science and entrepreneurial skills, translating great discoveries into potential breakthrough therapeutic
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
